Page last updated: 2024-10-31

metoprolol and Cancer of Prostate

metoprolol has been researched along with Cancer of Prostate in 3 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Zahalka, AH1
Fram, E1
Lin, W1
Mohn, L1
Frenette, PS1
Agalliu, I1
Watts, KL1
Posielski, NM1
Richards, KA1
Liou, JI1
Borza, T1
Abel, EJ1
Downs, TM1
Jarrard, DF1
Friedman, GD1
Udaltsova, N1
Habel, LA1

Other Studies

3 other studies available for metoprolol and Cancer of Prostate

ArticleYear
Use of beta-blocker types and risk of incident prostate cancer in a multiethnic population.
    Urologic oncology, 2020, Volume: 38, Issue:10

    Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Carvedilol; Humans; Image-Guided Biopsy; Incidence; Mal

2020
Beta-Adrenergic Antagonists and Cancer Specific Survival in Patients With Advanced Prostate Cancer: A Veterans Administration Cohort Study.
    Urology, 2021, Volume: 155

    Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Androgen Antagonists; Bone Neoplasm

2021
Norepinephrine antagonists and cancer risk.
    International journal of cancer, 2011, Feb-01, Volume: 128, Issue:3

    Topics: Atenolol; Breast Neoplasms; Clonidine; Colonic Neoplasms; Female; Humans; Lung Neoplasms; Male; Meto

2011